Clinical trial
Vasoreactivity in Carriers of Genetic Polymorphisms
NCT00160888 · Heidelberg University, Other · Unknown status
Key facts
| NCT number | NCT00160888 |
|---|---|
| Title | Vasoreactivity in Carriers of Genetic Polymorphisms |
| Official title | Endothelium-Dependent Vasoreactivity in Nitric Oxide Synthase Gene (Glu298Asp) Polymorphism: Studies in Healthy Volunteers |
| Lead sponsor | Heidelberg University, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | sodium nitroprusside, bradykinin, acetylcholine |
| Enrollment | 100 |
| Start date | Nov 1, 1999 |
| Completion | Dec 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 12, 2005 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: